BIO

Elisa holds a PhD in Pharmacology and Neuroscience jointly received from the Karolinska Institutet and the NIH, along with a MSc and BSc in Medical Biotechnology from Austria. During the past 15+ years, Elisa has gained extensive experience in the genome editing space, with a strong focus on immuno-oncology and cell therapies for cancer and autoimmunity. Before joining the team she held research and management positions in world-class academic institutions such as the National Institutes of Health and the Karolinska Institutet before moving into the pharmaceutical industry and startup scene gathering expertise in early R&D up to IND-enabling stage.